de Jonge MJ - Search Results

1

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.

van Haarst JM, Baas P, Manegold Ch, Schouwink JH, Burgers JA, de Bruin HG, Mooi WJ, van Klaveren RJ, de Jonge MJ, van Meerbeeck JP. van Haarst JM, et al. Among authors: de jonge mj, de bruin hg. Br J Cancer. 2002 Feb 1;86(3):342-5. doi: 10.1038/sj.bjc.6600118. Br J Cancer. 2002. PMID: 11875695 Free PMC article. Clinical Trial.

2

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Gerrits CJ, de Jonge MJ, Schellens JH, Stoter G, Verweij J. Gerrits CJ, et al. Among authors: de jonge mj. Br J Cancer. 1997;76(7):952-62. doi: 10.1038/bjc.1997.491. Br J Cancer. 1997. PMID: 9328159 Free PMC article. Review.

3

Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin.

Mathijssen RH, van Alphen RJ, de Jonge MJ, Verweij J, de Bruijn P, Loos WJ, Nooter K, Vernillet L, Stoter G, Sparreboom A. Mathijssen RH, et al. Among authors: de bruijn p, de jonge mj. Anticancer Drugs. 1999 Jan;10(1):9-16. doi: 10.1097/00001813-199901000-00002. Anticancer Drugs. 1999. PMID: 10194542 Clinical Trial.

4

Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors.

de Jonge MJ, Sparreboom A, Planting AS, van der Burg ME, de Boer-Dennert MM, ter Steeg J, Jacques C, Verweij J. de Jonge MJ, et al. Among authors: de boer dennert mm. J Clin Oncol. 2000 Jan;18(1):187-94. doi: 10.1200/JCO.2000.18.1.187. J Clin Oncol. 2000. PMID: 10623709 Clinical Trial.

5

Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin.

de Jonge MJ, Verweij J, de Bruijn P, Brouwer E, Mathijssen RH, van Alphen RJ, de Boer-Dennert MM, Vernillet L, Jacques C, Sparreboom A. de Jonge MJ, et al. Among authors: de bruijn p, de boer dennert mm. J Clin Oncol. 2000 Jan;18(1):195-203. doi: 10.1200/JCO.2000.18.1.195. J Clin Oncol. 2000. PMID: 10623710

6

Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer.

Gelderblom H, Sparreboom A, de Jonge MJ, Loos WJ, Wilms E, Mantel MA, Hennis B, Camlett I, Verweij J, van der Burg ME. Gelderblom H, et al. Among authors: de jonge mj. Br J Cancer. 2001 Oct 19;85(8):1124-9. doi: 10.1054/bjoc.2001.2014. Br J Cancer. 2001. PMID: 11710824 Free PMC article. Clinical Trial.

7

Influence of the cisplatin hydration schedule on topotecan pharmacokinetics.

Gelderblom H, Loos WJ, Sparreboom A, Soepenberg O, de Jonge MJ, van Boven-van Zomeren DM, Verweij J. Gelderblom H, et al. Among authors: de jonge mj. Eur J Cancer. 2003 Jul;39(11):1542-6. doi: 10.1016/s0959-8049(03)00316-2. Eur J Cancer. 2003. PMID: 12855260

8

Phase I pharmacological and bioavailability study of oral diflomotecan (BN80915), a novel E-ring-modified camptothecin analogue in adults with solid tumors.

Gelderblom H, Salazar R, Verweij J, Pentheroudakis G, de Jonge MJ, Devlin M, van Hooije C, Seguy F, Obach R, Pruñonosa J, Principe P, Twelves C. Gelderblom H, et al. Among authors: de jonge mj. Clin Cancer Res. 2003 Sep 15;9(11):4101-7. Clin Cancer Res. 2003. PMID: 14519632 Clinical Trial.

9

Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor.

Sparreboom A, Kehrer DF, Mathijssen RH, Xie R, de Jonge MJ, de Bruijn P, Planting AS, Eskens FA, Verheij C, de Heus G, Klaren A, Zhang S, Verhaeghe T, Palmer PA, Verweij J. Sparreboom A, et al. Among authors: de bruijn p, de heus g, de jonge mj. Br J Cancer. 2004 Apr 19;90(8):1508-15. doi: 10.1038/sj.bjc.6601732. Br J Cancer. 2004. PMID: 15083177 Free PMC article. Clinical Trial.

10

RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group.

Punt CJ, de Jonge MJ, Monfardini S, Daugaard G, Fiedler W, Baron B, Lacombe D, Fumoleau P; EORTC New Drug Development Group. Punt CJ, et al. Among authors: de jonge mj. Eur J Cancer. 2004 Jun;40(9):1332-4. doi: 10.1016/j.ejca.2004.02.016. Eur J Cancer. 2004. PMID: 15177492 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page